These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 35449157)

  • 21. Bufalin Inhibits Tumorigenesis and SREBP-1-Mediated Lipogenesis in Hepatocellular Carcinoma via Modulating the ATP1A1/CA2 Axis.
    Huang CJ; Zhang CY; Zhao YK; Wang D; Zhuang L; Qian L; Xie L; Zhu Y; Meng ZQ
    Am J Chin Med; 2023; 51(2):461-485. PubMed ID: 36655687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fructose-1,6-Bisphosphate Aldolase B Depletion Promotes Hepatocellular Carcinogenesis Through Activating Insulin Receptor Signaling and Lipogenesis.
    Liu G; Wang N; Zhang C; Li M; He X; Yin C; Tu Q; Shen X; Zhang L; Lv J; Wang Y; Jiang H; Chen S; Li N; Tao Y; Yin H
    Hepatology; 2021 Dec; 74(6):3037-3055. PubMed ID: 34292642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased de novo lipogenesis in liver contributes to the augmented fat deposition in dexamethasone exposed broiler chickens (Gallus gallus domesticus).
    Cai Y; Song Z; Zhang X; Wang X; Jiao H; Lin H
    Comp Biochem Physiol C Toxicol Pharmacol; 2009 Aug; 150(2):164-9. PubMed ID: 19393339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxisome Proliferator-Activated Receptor γ Expression Is Inversely Associated with Macroscopic Vascular Invasion in Human Hepatocellular Carcinoma.
    Hsu HT; Sung MT; Lee CC; Kuo YJ; Chi CW; Lee HC; Hsia CY
    Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27483249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice.
    Zhang W; Sun Q; Zhong W; Sun X; Zhou Z
    Alcohol Clin Exp Res; 2016 May; 40(5):988-99. PubMed ID: 27062444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deubiquitination of the repressor E2F6 by USP22 facilitates AKT activation and tumor growth in hepatocellular carcinoma.
    Jing T; Wang B; Yang Z; Liu Y; Xu G; Xu X; Jiao K; Chen Z; Xiang L; Zhang L; Liu Y
    Cancer Lett; 2021 Oct; 518():266-277. PubMed ID: 34339800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of peroxisome proliferator-activated receptor-gamma inhibits tumor growth by negatively regulating nuclear factor-κB activation in patients with hepatocellular carcinoma.
    Nojima H; Kuboki S; Shinoda K; Shimizu H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Takayashiki T; Miyazaki M
    J Hepatobiliary Pancreat Sci; 2016 Sep; 23(9):574-84. PubMed ID: 27451128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BCAT2 promotes melanoma progression by activating lipogenesis via the epigenetic regulation of FASN and ACLY expressions.
    Tian Y; Ma J; Wang H; Yi X; Wang H; Zhang H; Guo S; Yang Y; Zhang B; Du J; Shi Q; Gao T; Guo W; Li C
    Cell Mol Life Sci; 2023 Oct; 80(11):315. PubMed ID: 37801083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma.
    Lally JSV; Ghoshal S; DePeralta DK; Moaven O; Wei L; Masia R; Erstad DJ; Fujiwara N; Leong V; Houde VP; Anagnostopoulos AE; Wang A; Broadfield LA; Ford RJ; Foster RA; Bates J; Sun H; Wang T; Liu H; Ray AS; Saha AK; Greenwood J; Bhat S; Harriman G; Miao W; Rocnik JL; Westlin WF; Muti P; Tsakiridis T; Harwood HJ; Kapeller R; Hoshida Y; Tanabe KK; Steinberg GR; Fuchs BC
    Cell Metab; 2019 Jan; 29(1):174-182.e5. PubMed ID: 30244972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ubiquitin-specific protease 22 promotes tumorigenesis and progression by an FKBP12/mTORC1/autophagy positive feedback loop in hepatocellular carcinoma.
    Ye Q; Zhou W; Xu S; Que Q; Zhan Q; Zhang L; Zheng S; Ling S; Xu X
    MedComm (2020); 2023 Dec; 4(6):e439. PubMed ID: 38045832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ZHX2 inhibits SREBP1c-mediated de novo lipogenesis in hepatocellular carcinoma via miR-24-3p.
    Yu X; Lin Q; Wu Z; Zhang Y; Wang T; Zhao S; Song X; Chen C; Wang Z; Xu L; Li C; Gao L; Liang X; Yue X; Ma C
    J Pathol; 2020 Dec; 252(4):358-370. PubMed ID: 32770671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose-dependent de novo lipogenesis in B lymphocytes: a requirement for atp-citrate lyase in lipopolysaccharide-induced differentiation.
    Dufort FJ; Gumina MR; Ta NL; Tao Y; Heyse SA; Scott DA; Richardson AD; Seyfried TN; Chiles TC
    J Biol Chem; 2014 Mar; 289(10):7011-7024. PubMed ID: 24469453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. mTORC2-AKT signaling to ATP-citrate lyase drives brown adipogenesis and de novo lipogenesis.
    Martinez Calejman C; Trefely S; Entwisle SW; Luciano A; Jung SM; Hsiao W; Torres A; Hung CM; Li H; Snyder NW; Villén J; Wellen KE; Guertin DA
    Nat Commun; 2020 Jan; 11(1):575. PubMed ID: 31996678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of peroxisome proliferator-activated receptor-γ (PPARγ) inhibits hepatoma cell growth via downregulation of SEPT2 expression.
    Cao LQ; Shao ZL; Liang HH; Zhang DW; Yang XW; Jiang XF; Xue P
    Cancer Lett; 2015 Apr; 359(1):127-35. PubMed ID: 25592041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acetyl-coenzyme A carboxylase alpha promotion of glucose-mediated fatty acid synthesis enhances survival of hepatocellular carcinoma in mice and patients.
    Wang MD; Wu H; Fu GB; Zhang HL; Zhou X; Tang L; Dong LW; Qin CJ; Huang S; Zhao LH; Zeng M; Wu MC; Yan HX; Wang HY
    Hepatology; 2016 Apr; 63(4):1272-86. PubMed ID: 26698170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the Role of ATP-Citrate Lyase in the Immune System.
    Dominguez M; Brüne B; Namgaladze D
    Front Immunol; 2021; 12():632526. PubMed ID: 33679780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor{gamma} ligands in vitro and in vivo.
    Hsu MC; Huang CC; Chang HC; Hu TH; Hung WC
    Clin Cancer Res; 2008 Jul; 14(13):4045-52. PubMed ID: 18593980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ménage à trois of autophagy, lipid droplets and liver disease.
    Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F
    Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
    Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
    J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.
    Du D; Liu C; Qin M; Zhang X; Xi T; Yuan S; Hao H; Xiong J
    Acta Pharm Sin B; 2022 Feb; 12(2):558-580. PubMed ID: 35256934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.